BP-lowering drugs reduced major CV events by similar amounts in patients with and without type 2 diabetes

Jayson C Carr

doi:10.7326/J22-0093

BP-lowering drugs reduced major CV events by similar amounts in patients with and without type 2 diabetes

Ann Intern Med. 2022 Dec;175(12):JC138. doi: 10.7326/J22-0093. Epub 2022 Dec 6.

Author

Jayson C Carr¹

Affiliation

¹ Beth Israel Lahey Primary Care, Boston, Massachusetts, USA (J.C.C.).

PMID: 36469918
DOI: 10.7326/J22-0093

Abstract

Nazarzadeh M, Bidel Z, Canoy D, et al. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. Lancet Diabetes Endocrinol. 2022;10:645-54. 35878651.

Publication types

Comment

MeSH terms

Antihypertensive Agents / therapeutic use
Blood Pressure
Cardiovascular Diseases* / prevention & control
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypertension* / drug therapy
Meta-Analysis as Topic

Substances

Antihypertensive Agents